Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00337675
Status:
COMPLETED
Last Update Posted:
2024-05-10
First Post:
2006-06-14
Brief Title:
Intermittent and Daily Dosing for Episodic Periodic Asthma 0476-302COMPLETED
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Double-Dummy Parallel-Group Study Evaluating the Effects of 2 Different Regimens of Montelukast Daily Dosing and Intermittent Episode-Driven Dosing Compared With Placebo in the Treatment of Episodic Asthma in Children Aged 6 Months to 5 Years
Status:
COMPLETED
Status Verified Date:
2022-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a year-long study evaluating the efficacy of both daily and intermittent treatment of asthma in children who experience symptoms episodically ie seasonally usually in the context of upper respiratory tract infection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006_015 | None | None | None |
| MK0476-302 | None | None | None |